Table 4:
Patients who had progression free survival ≥6 months
| Patient number |
Dose Level | Prior Regimens* | Response | Disease site | Cycles |
|---|---|---|---|---|---|
| 5 | 2 | 4 | CR | Ovary | 6 (off for abdominal pain) |
| 6 | 2 | 1 | SD | Pylorus (signet ring cell) | 12 (off for PD) |
| 7 | 2 | 1 | SD | Pancreas | 18 (off for PD) |
| 8 | 2 | 2 | SD | Appendix (mucin) | 18 (off for PD) |
| 10 | 3 | 4 | SD | Appendix (mucin producing) | 10 (off for PD) |
| 13 | 4 | 2 | SD | Cervix uteri | 1 (off for DLT) |
| 18 | 5 | 1 | PR | Uterus | 12 (off for PD) |
| 24 | 5 | 2 | SD | Cervix uteri | 6 (chemical peritonitis and pleural effusion) |
*
count includes adjuvant chemotherapy and subsequent regimens for recurrent disease